IN2012DN02137A - - Google Patents

Download PDF

Info

Publication number
IN2012DN02137A
IN2012DN02137A IN2137DEN2012A IN2012DN02137A IN 2012DN02137 A IN2012DN02137 A IN 2012DN02137A IN 2137DEN2012 A IN2137DEN2012 A IN 2137DEN2012A IN 2012DN02137 A IN2012DN02137 A IN 2012DN02137A
Authority
IN
India
Prior art keywords
pharmaceutical compositions
chemotherapy
vitamin
compound
alopecia
Prior art date
Application number
Inventor
Joaquin J Jimenez
Niven Rajin Narain
John Patrick Mccook
Original Assignee
Berg Biosystems Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berg Biosystems Llc filed Critical Berg Biosystems Llc
Publication of IN2012DN02137A publication Critical patent/IN2012DN02137A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

The invention provides methods and pharmaceutical compositions for preventing or treating alopecia, such as chemotherapy-induced alopecia (CIA). The pharmaceutical compositions of the invention comprises an effective amount of a vitamin D compound in a formulation that topically delivers the vitamin D compound to the epidermis layer but substantially avoids the dermis layer. In chemotherapy patients, the pharmaceutical compositions of the invention can be administered either before or concurrent with the chemotherapy medication.
IN2137DEN2012 2009-08-14 2010-08-06 IN2012DN02137A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23417809P 2009-08-14 2009-08-14
PCT/US2010/044765 WO2011019617A2 (en) 2009-08-14 2010-08-06 Vitamin d3 and analogs thereof for treating alopecia

Publications (1)

Publication Number Publication Date
IN2012DN02137A true IN2012DN02137A (en) 2015-08-07

Family

ID=43586756

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2137DEN2012 IN2012DN02137A (en) 2009-08-14 2010-08-06

Country Status (18)

Country Link
US (2) US9901637B2 (en)
EP (2) EP2464357B1 (en)
JP (2) JP5978130B2 (en)
KR (2) KR101791828B1 (en)
CN (3) CN106265695B (en)
AR (1) AR077922A1 (en)
AU (3) AU2010282731C1 (en)
BR (1) BR112012003372A2 (en)
CA (1) CA2770683C (en)
EA (1) EA201270226A1 (en)
ES (1) ES2742750T3 (en)
IL (1) IL218043B (en)
IN (1) IN2012DN02137A (en)
MX (2) MX338746B (en)
SG (2) SG178382A1 (en)
TW (2) TW201733593A (en)
WO (1) WO2011019617A2 (en)
ZA (2) ZA201702812B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100196308A1 (en) * 2009-01-27 2010-08-05 Jimenez Joaquin J Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
WO2011019617A2 (en) 2009-08-14 2011-02-17 Cytotech Labs, Llc Vitamin d3 and analogs thereof for treating alopecia
JP5537352B2 (en) * 2010-09-09 2014-07-02 花王株式会社 Hair growth inhibitor
CN103118661B (en) * 2010-09-09 2017-09-22 花王株式会社 Hair-growth control method, the evaluation of hair growth controlling agent or system of selection and hair growth inhibitor
JP5654808B2 (en) * 2010-09-09 2015-01-14 花王株式会社 Method for evaluating or selecting hair growth regulator
FR2996128B1 (en) * 2012-09-28 2015-01-02 Inneov Lab USE OF AN ASSOCIATION OF TAURINE OR ONE OF ITS DERIVATIVES, AND GRAPE EXTRACT FOR IMPROVING THE QUALITY OF NAILS.
CN105188400B (en) * 2013-03-15 2024-04-05 马斯公司 Compositions and methods for preventing, alleviating, relieving or treating idiopathic vomiting
HK1222819A1 (en) * 2013-05-29 2017-07-14 博格有限责任公司 Preventing or mitigating chemotherapy induced alopecia using vitamin d
WO2017147420A1 (en) * 2016-02-25 2017-08-31 The University Of Florida Research Foundation, Inc. Methods and compositions with vitamin d compounds for treatment of cystic fibrosis and respiratory disorders
CN105842459A (en) * 2016-03-24 2016-08-10 泰州海路生物技术有限公司 Immuno-chromatography kit for quickly and quantitatively detecting calprotectin in excrement
EP3463283A4 (en) * 2016-06-05 2020-04-01 Berg LLC PREVENTING OR REDUCING CHEMOTHERAPY-INDUCED ALOPECIA BY USING VITAMIN D
US10500217B2 (en) 2018-04-30 2019-12-10 Leslie Ray Matthews, M.D., Llc Vitamin D3, heat shock proteins, and glutathione for the treatment of chronic inflammation and chronic diseases
US20220233641A1 (en) * 2019-05-17 2022-07-28 The Trustees Of The University Of Pennsylvania Methods and Compositions for Treating Obesity and/or Skin Disorders
CN110604098B (en) * 2019-09-23 2021-09-07 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） A method for constructing an animal model of rheumatoid arthritis complicated with interstitial lung disease
KR20250029225A (en) 2022-07-01 2025-03-04 제이제이알앤디 엘엘씨 Methods for preventing and treating chemotherapy-induced alopecia

Family Cites Families (169)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4425916A (en) 1979-06-01 1984-01-17 Therapeutic Products, Inc. Cap structure for creating temperature controlled environment for reducing alopecia
US4248791A (en) 1980-02-04 1981-02-03 Wisconsin Alumni Research Foundation 25-Hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol
US4307231A (en) 1980-07-18 1981-12-22 Wisconsin Alumni Research Foundation Vitamin D-lactone derivative and process for preparing same
US4336193A (en) 1980-08-04 1982-06-22 Wisconsin Alumni Research Foundation Process for preparing vitamin D-lactones
US4279826A (en) 1980-09-22 1981-07-21 Wisconsin Alumni Research Foundation 23,25-Dihydroxyvitamin D3
US4367177A (en) 1981-04-15 1983-01-04 Wisconsin Alumni Research Foundation Process for preparing 23,25-dihydroxyvitamin D3
US4305880A (en) 1980-09-22 1981-12-15 Wisconsin Alumni Research Foundation Process for preparing 24-fluoro-25-hydroxycholecalciferol
US4307025A (en) 1981-02-17 1981-12-22 Wisconsin Alumni Research Foundation 1α, 25-dihydroxy-2β-fluorovitamin D3
JPS57149224A (en) 1981-03-13 1982-09-14 Chugai Pharmaceut Co Ltd Tumor-suppressing agent
US4358406A (en) 1981-07-27 1982-11-09 Wisconsin Alumni Research Foundation 26,26,26,27,27,27-Hexafluoro-1α,25-dihydroxycholecalciferol and process for preparing same
US4360471A (en) 1981-12-11 1982-11-23 Wisconsin Alumni Research Foundation 23-Dehydro-25-hydroxyvitamin D3
US4360472A (en) 1981-12-11 1982-11-23 Wisconsin Alumni Research Foundation Trihydroxyvitamin D3 compounds
US4411833A (en) 1982-05-26 1983-10-25 Wisconsin Alumni Research Foundation Method for preparing 26,26,26,27,27,27-hexafluoro-1α,25-dihydroxycholesterol
US4428946A (en) 1982-07-26 1984-01-31 Wisconsin Alumni Research Foundation Method of preventing milk fever in dairy cattle
US4448721A (en) 1982-09-20 1984-05-15 Wisconsin Alumni Research Foundation Hydroxyvitamin D2 compounds and process for preparing same
US5036061A (en) 1983-05-09 1991-07-30 Deluca Hector F Process for the preparation of 1 alpha,25-dihydroxylated vitamin D2 and related compounds
US4448726A (en) 1983-05-11 1984-05-15 Wisconsin Alumni Research Foundation Ring A- and triene-modified vitamin D compounds
US4502991A (en) 1983-08-18 1985-03-05 Wisconsin Alumni Research Foundation 23,23-Difluoro-1α,25-dihydroxy-vitamin D3
US4564474A (en) 1983-08-18 1986-01-14 Wisconsin Alumni Research Foundation 23,23-Difluoro-25-hydroxy-vitamin D3 and process for preparing same
US4769181A (en) 1983-11-07 1988-09-06 Wisconsin Alumni Research Foundation 1,25-dihydroxyvitamin D2 compounds
US4719205A (en) 1984-01-30 1988-01-12 Wisconsin Alumini Research Foundation Side-chain unsaturated 1-hydroxyvitamin D compounds
US4689180A (en) 1984-01-30 1987-08-25 Wisconsin Alumni Research Foundation 1α,25-dihydroxy-22Z-dehydroxyvitamin D compound
US4505906A (en) 1984-01-30 1985-03-19 Wisconsin Alumni Research Foundation Hydroxyvitamin D2 isomers
US5120722A (en) 1984-02-08 1992-06-09 Hoffmann-La Roche Inc. Trihydroxy-cholecacliferol and trihydroxy-ergocalciferol for treating leukemia
US4481198A (en) 1984-02-13 1984-11-06 Wisconsin Alumni Research Foundation Vitamin D metabolism inhibitor
US4719204A (en) 1984-03-05 1988-01-12 Wisconsin Alumni Research Foundation Fowl bone mineralization with 28-NOR 1α-hydroxyvitamin D2 analogs
US4566455A (en) 1984-03-27 1986-01-28 H. Mervin Hughes, II Skin temperature control
US4588716A (en) 1984-05-04 1986-05-13 Wisconsin Alumni Research Foundation Method for treating metabolic bone disease in mammals
US4588528A (en) 1984-05-31 1986-05-13 Wisconsin Alumni Research Foundation 1,24-dihydroxy-Δ22 -vitamin D3 and process for preparing same
US4857518A (en) 1984-10-04 1989-08-15 Wisconsin Alumni Research Foundation Hydroxylated 24-homo-vitamin D derivatives and methods for preparing same
US4717721A (en) 1985-05-30 1988-01-05 Howard W. Bremer Sidechain homo-vitamin D compounds with preferential anti-cancer activity
JPS62501505A (en) 1985-01-17 1987-06-18 ウイスコンシン　アラムナイ　リサ−チ　フオンデ−シヨン vitamin D derivatives
US4594192A (en) 1985-03-20 1986-06-10 Wisconsin Alumni Research Foundation 2α-fluorovitamin D3
JPS62502545A (en) 1985-04-23 1987-10-01 ウイスコンシン　アラムナイ　リサ−チ　フオンデ−シヨン Secosterol compounds
US4755329A (en) 1985-06-10 1988-07-05 Wisconsin Alumni Research Foundation Process and intermediates for preparing 1α-hydroxyvitamin D compounds
WO1987000834A1 (en) 1985-08-02 1987-02-12 Leo Pharmaceutical Products Ltd. A/S Novel vitamin d analogues
US4619920A (en) 1985-09-16 1986-10-28 Wisconsin Alumni Research Foundation 26,26,26,27,27-pentafluoro-1α-hydroxy-27-methoxyvitamin D3
US5017371A (en) 1988-01-06 1991-05-21 Amarillo Cell Culture Company, Incorporated Method for reducing side effects of cancer therapy
US5145846A (en) 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
US4804502A (en) 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
US5342411A (en) 1988-04-16 1994-08-30 Greater Glasgow Health Board Scalp cooling device
US5354744A (en) 1988-04-29 1994-10-11 Wisconsin Alumni Research Foundation Side chain unsaturated 1 alpha-hydroxyvitamin D analogs
US4927815A (en) 1988-04-29 1990-05-22 Wisconsin Alumni Research Foundation Compounds effective in inducing cell differentiation and process for preparing same
US5250523A (en) 1988-04-29 1993-10-05 Wisconsin Alumni Research Foundation Side chain unsaturated 1α-hydroxyvitanim D homologs
US4847012A (en) 1988-04-29 1989-07-11 Wisconsin Alumni Research Foundation Vitamin D related compounds and processes for their preparation
US5232836A (en) 1988-05-04 1993-08-03 Ire-Medgenix S.A. Vitamin D derivatives: therapeutic applications and applications to assays of metabolites of vitamin D
US4851401A (en) 1988-07-14 1989-07-25 Wisconsin Alumni Research Foundation Novel cyclopentano-vitamin D analogs
US5321018A (en) 1989-03-09 1994-06-14 Wisconsin Alumni Research Foundation Use of 1α-hydroxylated-19-nor-vitamin D compounds to treat psoriasis
US5246925A (en) 1989-03-09 1993-09-21 Wisconsin Alumni Research Foundation 19-nor-vitamin D compounds for use in treating hyperparathyroidism
CA1333616C (en) 1989-03-09 1994-12-20 Hector F. Deluca 19-nor-vitamin d compounds
US4973584A (en) 1989-03-09 1990-11-27 Deluca Hector F Novel 1α-hydroxyvitamin D2 epimer and derivatives
DE3933034A1 (en) 1989-10-02 1991-04-11 Schering Ag 24-HOMO-VITAMIN-D DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF
US5254538A (en) 1989-10-04 1993-10-19 Trustees Of Boston University Method of treating periodontal disease
US5532228A (en) 1990-02-06 1996-07-02 Schering Aktiengesellschaft Side-chain homologous vitamin D derivatives, process for their production, pharmaceutical preparations containing these derivatives and their use as pharmaceutical agents
US5260290A (en) 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
US5030772A (en) 1990-02-14 1991-07-09 Deluca Hector F Process for preparing vitamin D2 compounds and the corresponding 1 α-hydroxylated derivatives
GB9007236D0 (en) 1990-03-30 1990-05-30 Leo Pharm Prod Ltd Chemical compounds
GB9017890D0 (en) 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
US5185150A (en) 1990-08-24 1993-02-09 Wisconsin Alumni Research Fdn. Cosmetic compositions containing 19-nor-vitamin D compounds
DE4101953A1 (en) 1991-01-19 1992-07-23 Schering Ag 23-OXA DERIVATIVES IN THE VITAMIN-D SERIES, METHOD FOR THE PRODUCTION THEREOF THE PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES AND THE USE THEREOF AS MEDICINAL PRODUCTS
AU650751B2 (en) 1991-05-28 1994-06-30 Wisconsin Alumni Research Foundation Novel synthesis of 19-nor vitamin D compounds
US5086191A (en) 1991-05-28 1992-02-04 Wisconsin Alumni Research Foundation Intermediates for the synthesis of 19-nor vitamin D compounds
US5486509A (en) * 1991-06-28 1996-01-23 University Of Miami Method of preventing and treating chemotherapy-induced alopecia
HUT66153A (en) 1991-06-28 1994-09-28 Univ Miami Pharmaceutical compositions which can be used for preventing and treating of chemotherapy-induced alopecia
ES2093180T3 (en) 1991-07-05 1996-12-16 Duphar Int Res VITAMIN D COMPOUND, METHOD OF PREPARING THIS COMPOUND AND INTERMEDIATE PRODUCT OF SUCH METHOD.
DE4141746A1 (en) 1991-12-13 1993-06-17 Schering Ag 20-METHYL-SUBSTITUTED VITAMIN D DERIVATIVES
EP0549318B1 (en) 1991-12-26 1996-10-16 Wisconsin Alumni Research Foundation 26,27-Dimethylene-1 alpha, 25-dihydroxyvitamin D2 and 26,27-dihydroxyvitamin D2 and methods for preparing same
GB9201920D0 (en) * 1992-01-29 1992-03-18 Leo Pharm Prod Ltd Novel treatment i
US5830885A (en) 1992-03-12 1998-11-03 The Johns Hopkins University Antiproliferative vitamin D3 hybrids
GB9206648D0 (en) 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
KR960013798B1 (en) 1992-04-24 1996-10-10 재단법인 한국전자통신연구소 Planar Waveguide Type Space Switch
AU666529B2 (en) 1992-04-24 1996-02-15 Wisconsin Alumni Research Foundation Method of treating osteoporosis with 1 alpha, 24 (R)-dihydroxy-22 (E)-dehydro-vitamin D3
JP2876547B2 (en) 1992-06-23 1999-03-31 呉羽化学工業株式会社 Anti-Kur disease agent
DE4220757A1 (en) 1992-06-24 1994-01-05 Schering Ag Derivatives in the vitamin D series with modifications in the 20-position, process for their preparation, intermediates for this process, pharmaceutical preparations containing these derivatives and their use in the manufacture of medicaments
DE4221961A1 (en) 1992-06-30 1994-01-05 Schering Ag 22-en-25-oxa derivatives in the vitamin D series, processes for their preparation, pharmaceutical preparations containing these derivatives and their use as medicines
GB9214202D0 (en) 1992-07-03 1992-08-12 Leo Pharm Prod Ltd Chemical compounds
US5194431A (en) 1992-07-08 1993-03-16 Wisconsin Alumni Research Foundation 24-cyclopropane vitamin D derivatives
AU666563B2 (en) 1992-08-07 1996-02-15 Wisconsin Alumni Research Foundation Preparation of 19-nor-vitamin D compounds
IL103224A (en) 1992-09-18 1998-08-16 Teva Pharma Stabilized pharmaceutical compositions containing derivatives of vitamins d2 and d3
GB9220272D0 (en) 1992-09-25 1992-11-11 Leo Pharm Prod Ltd Chemical compounds
GB9220439D0 (en) 1992-09-28 1992-11-11 Leo Pharm Prod Ltd Chemical compounds
IL107185A (en) 1992-10-06 1998-02-22 Schering Ag Vitamin d, 25-carboxylic acid derivatives and pharmaceutical compositions containing the same
GB9223061D0 (en) 1992-11-04 1992-12-16 Leo Pharm Prod Ltd Chemical compounds
US5247104A (en) 1992-11-04 1993-09-21 Wisconsin Alumni Research Foundation Preparation of 1α, 24-dihydroxyvitamin D analogs
AU685741B2 (en) 1992-12-04 1998-01-29 Mayor Pharmaceutical Laboratories, Inc. Sprayable analgesic composition and method of use
GB9226877D0 (en) 1992-12-23 1993-02-17 Leo Pharm Prod Ltd Chemical compounds
CA2152163A1 (en) 1992-12-29 1994-07-07 Michael F. Holick Use of vitamin d glycosides for the treatment or prevention of osteoporosis
US5547947A (en) 1993-03-11 1996-08-20 Hoffmann-La Roche Inc. Methods of treatment
GB9309422D0 (en) 1993-05-07 1993-06-23 Res Inst Medicine Chem Chemical compounds
US5371249A (en) 1993-05-11 1994-12-06 Wisconsin Alumni Research Foundation Iodo vitamin D3 compounds and method for preparing same
US5449668A (en) 1993-06-04 1995-09-12 Duphar International Research B.V. Vitamin D compounds and method of preparing these compounds
DK0707566T3 (en) 1993-07-09 2000-09-04 Theramex Hitherto unknown structural analogues for vitamin D
GB9314400D0 (en) 1993-07-12 1993-08-25 Leo Pharm Prod Ltd Produktionsaktieselskab) chemical compounds
GB9315253D0 (en) 1993-07-23 1993-09-08 Res Inst Medicine Chem Chemical compounds
US5565589A (en) 1993-11-03 1996-10-15 Wisconsin Alumni Research Foundation 17-formyl-5,6-trans-vitamin D compounds
US5552392A (en) 1993-11-03 1996-09-03 Wisconsin Alumni Research Foundation Method of treating hypoparathyroidism with (20S) vitamin D compounds
US5384313A (en) 1993-11-24 1995-01-24 Wisconsin Alumni Research Foundation 21-norvitamin D compounds
US5373004A (en) 1993-11-24 1994-12-13 Wisconsin Alumni Research Foundation 26,28-methylene-1α, 25-dihydroxyvitamin D2 compounds
GB9325415D0 (en) 1993-12-13 1994-02-16 Res Inst Medicine Chem Chemical compounds
US6103709A (en) 1993-12-23 2000-08-15 The Regents Of The University Of California Therapeutically effective 1α,25-dihydroxyvitamin D3 analogs and methods for treatment of vitamin D diseases
GB9405715D0 (en) 1994-03-23 1994-05-11 Res Inst Medicine Chem Chemical compounds
CN1046502C (en) 1994-04-11 1999-11-17 中外制药株式会社 22-Thiovitamin D3 Derivatives
KR970707089A (en) 1994-11-21 1997-12-01 리차드 에이취. 리이저 18, 19-Dinor-Vitamin D Compounds < RTI ID = 0.0 >
US5661140A (en) 1994-11-21 1997-08-26 Wisconsin Alumni Research Foundation 18-nor-vitamin D compounds
DE69508895T2 (en) 1994-12-14 1999-10-21 Duphar International Research B.V., Weesp Vitamin D derivatives and methods of making these compounds
DK0806413T3 (en) 1995-01-23 2002-01-28 Chugai Pharmaceutical Co Ltd 2-substituted viatmin D3 derivatives
US5877168A (en) 1995-02-10 1999-03-02 Chugai Seiyaku Kabushiki Kaisha Vitamin D derivative with substituent at the 2β-position
JPH08295628A (en) * 1995-04-27 1996-11-12 Teijin Ltd External agent for treatment of alopecia
DE19519273A1 (en) * 1995-05-22 1996-11-28 Schering Ag Topical agents for the treatment and prophylaxis of alopecia
US6844326B2 (en) 1995-06-07 2005-01-18 Anticancer, Inc. Treatment of alopecia
JPH11507649A (en) 1995-06-14 1999-07-06 シエーリング アクチエンゲゼルシヤフト Novel Vitamin D Derivatives Having a Substituent at the 25-Position Carbon, Processes for Their Preparation, Intermediates and Their Use for the Preparation of Pharmaceuticals
DK0771789T3 (en) 1995-10-30 2000-06-13 Hoffmann La Roche 1 alpha, 26-dihydroxy-D-homo-vitamin D3
GB9524812D0 (en) 1995-12-05 1996-02-07 Leo Pharm Prod Ltd Chemical compounds
GB9526208D0 (en) 1995-12-21 1996-02-21 Res Inst Medicine Chem Chemical compounds
GB9607034D0 (en) 1996-04-03 1996-06-05 Leo Pharm Prod Ltd Chemical compounds
JP2000509405A (en) 1996-05-02 2000-07-25 デユフアー・インターナシヨナル・リサーチ・ベー・ブイ Vitamin D analogs and methods for producing these compounds
JPH09299484A (en) 1996-05-10 1997-11-25 Maeda Sangyo Kk Syringe spray pump
GB9611603D0 (en) 1996-06-04 1996-08-07 Leo Pharm Prod Ltd Chemical compounds
US5976784A (en) 1996-09-20 1999-11-02 Wisconsin Alumni Research Foundation Calcitriol derivatives and their uses
GB9622590D0 (en) 1996-10-30 1997-01-08 Leo Pharm Prod Ltd Chemical compounds
ES2206758T3 (en) 1996-12-20 2004-05-16 Chugai Seiyaku Kabushiki Kaisha DERIVATIVES OF VITAMIN D 16-JAN.
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
US5945410A (en) 1997-03-17 1999-08-31 Wisconsin Alumni Research Foundation 2-alkyl-19-nor-vitamin D compounds
US6392071B1 (en) 1997-03-17 2002-05-21 Wisconsin Alumni: Research Foundation 26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds
DK0884308T3 (en) 1997-05-02 2003-07-21 Duphar Int Res Process for Preparation of 16-Dehydro Vitamin D Compounds
ATE322477T1 (en) 1997-05-16 2006-04-15 Woman & Infants Hospital 3-EPI-VITAMIN D2 COMPOUNDS AND THEIR APPLICATIONS
EP1011683A4 (en) 1997-05-22 2003-06-11 Cephalon Inc VITAMIN D ANALOGS AND THE EFFECT ON NEURONES
AU7454698A (en) 1997-06-06 1998-12-21 Shionogi & Co., Ltd. Improvement in medicament administration system
AUPO727097A0 (en) 1997-06-10 1997-07-03 Unisearch Limited Method of treatment of hepatoma and pharmaceutical compositions for use therein
US5936105A (en) 1997-06-13 1999-08-10 Tetrionics, Inc. 14-EPI-19-nor-vitamin D compounds and methods
US5939406A (en) 1997-07-21 1999-08-17 Wisconsin Alumni Research Foundation 18-substituted-19-nor-vitamin D compounds
US6359152B2 (en) 1997-07-21 2002-03-19 Wisconsin Alumni Research Foundation 18-substituted-19-nor-vitamin D compounds
GB9721156D0 (en) 1997-10-06 1997-12-03 Leo Pharm Prod Ltd Novel vitamin d analogues
US5919986A (en) 1997-10-17 1999-07-06 Hoffmann-La Roche Inc. D-homo vitamin D3 derivatives
US6043385A (en) 1997-12-16 2000-03-28 Hoffman-La Roche Inc. Vitamin D derivatives
JP2002508383A (en) * 1997-12-17 2002-03-19 シエーリング アクチエンゲゼルシャフト Vitamin D derivative having phosphorus atom in side chain
US6184422B1 (en) 1998-02-26 2001-02-06 Hoffman-La Roche Inc. Cyclohexanediol derivatives
ES2368824T3 (en) 1998-03-27 2011-11-22 Oregon Health & Science University VITAMIN D AND ITS ANALOGS IN THE TREATMENT OF TUMORS AND OTHER HYPERPROLIFERATIVE DISORDERS.
WO1999052863A1 (en) 1998-04-10 1999-10-21 Chugai Seiyaku Kabushiki Kaisha VITAMIN D DERIVATIVES SUBSTITUTED AT THE 2β-POSITION
US6114317A (en) 1998-05-21 2000-09-05 Wisconsin Alumni Research Foundation Method of locking 1α-OH of vitamin D compounds in axial orientation
US5972917A (en) 1998-05-29 1999-10-26 Bone Care Int Inc 1 α-hydroxy-25-ene-vitamin D, analogs and uses thereof
ATE246172T1 (en) 1998-05-29 2003-08-15 Bone Care Int Inc METHOD FOR PRODUCING HYDROXY-25-ENE VITAMIN D COMPOUNDS
US20010002396A1 (en) 1998-07-16 2001-05-31 Charles Achkar Compositions and methods of treating skin conditions
US6218430B1 (en) 1998-08-24 2001-04-17 Ligand Pharmaceuticals Incorporated Vitamin D3 mimics
CA2348235A1 (en) * 1998-10-23 2000-05-04 Teijin Limited Vitamin d3 derivatives and treating agent for inflammatory respiratory disease using same
FR2785284B1 (en) * 1998-11-02 2000-12-01 Galderma Res & Dev VITAMIN D ANALOGS
US6238683B1 (en) * 1998-12-04 2001-05-29 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
KR200257098Y1 (en) * 1999-01-21 2001-12-24 신석균 Bith seinse stereo scope
FR2801307B1 (en) 1999-11-24 2002-12-06 Galderma Res & Dev VITAMIN D ANALOGS
FR2801305B1 (en) 1999-11-24 2002-12-06 Galderma Res & Dev VITAMIN D ANALOGS
US6358939B1 (en) 1999-12-21 2002-03-19 Northern Lights Pharmaceuticals, Llc Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
WO2002030430A1 (en) * 2000-10-06 2002-04-18 Abbott Laboratories Use of vitamin d2 compounds for alopecia
FR2825087B1 (en) * 2001-05-22 2005-01-14 Galderma Res & Dev ANALOGUES OF VITAMIN D
GB0128628D0 (en) 2001-11-29 2002-01-23 Univ Sheffield Disease treatment
TW200303206A (en) * 2002-02-20 2003-09-01 Teijin Ltd Vitamin D3 derivatives and remedies using the same
US20040053895A1 (en) * 2002-09-18 2004-03-18 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
AR041696A1 (en) * 2002-10-23 2005-05-26 Leo Pharm Prod Ltd VITAMIN D ANALOG COMPOUNDS, COMPOSITIONS THAT INCLUDE SUCH ANALOG COMPOUNDS AND THEIR USE
BR0315553A (en) * 2002-10-23 2005-08-23 Leo Pharma As Compound, pharmaceutical composition, method of treatment or prophylaxis of diseases, method of treatment or prophylaxis of secondary hyperparathyroidism, and use of a compound, optionally in conjunction with another therapeutically active compound
AU2004247109A1 (en) 2003-06-11 2004-12-23 Novacea, Inc Treatment of cancer with active vitamin D compounds in combination with radiotherapeutic agents and treatments
AU2004282162B2 (en) 2003-10-14 2012-01-19 X-Ceptor Therapeutics, Inc. Bridged ring structures as pharmaceutical agents
EP1686972B1 (en) 2003-11-21 2008-03-12 Galderma Research & Development Sprayable composition for the administration of vitamin d derivatives
FR2862540B1 (en) 2003-11-21 2007-03-30 Galderma Res & Dev SPRAY COMPOSITION COMPRISING A PHARMACEUTICAL ACTIVE, AT LEAST ONE VOLATILE SILICONE AND A NON-VOLATILE NON-POLAR PHASE
AU2006245282A1 (en) * 2005-05-10 2006-11-16 Dermipsor Ltd. Compositions and methods for skin care
CN1732902A (en) 2005-09-01 2006-02-15 晏四平 Vitamin contained spray
US8530463B2 (en) 2007-05-07 2013-09-10 Hale Biopharma Ventures Llc Multimodal particulate formulations
JP2011513428A (en) * 2008-03-06 2011-04-28 ウイスコンシン アラムナイ リサーチ ファウンデーシヨン Method for increasing epidermal thickness by topical administration of 19-nor containing vitamin D compound
WO2011019617A2 (en) 2009-08-14 2011-02-17 Cytotech Labs, Llc Vitamin d3 and analogs thereof for treating alopecia
HK1222819A1 (en) 2013-05-29 2017-07-14 博格有限责任公司 Preventing or mitigating chemotherapy induced alopecia using vitamin d
EP3463283A4 (en) 2016-06-05 2020-04-01 Berg LLC PREVENTING OR REDUCING CHEMOTHERAPY-INDUCED ALOPECIA BY USING VITAMIN D

Also Published As

Publication number Publication date
AU2017210660B2 (en) 2019-04-18
JP6336523B2 (en) 2018-06-06
US20180369381A1 (en) 2018-12-27
SG10201404883YA (en) 2014-10-30
SG178382A1 (en) 2012-04-27
TW201110971A (en) 2011-04-01
AU2010282731A1 (en) 2012-03-08
TWI595877B (en) 2017-08-21
AR077922A1 (en) 2011-10-05
CA2770683C (en) 2018-09-04
CN106265695B (en) 2021-05-07
AU2010282731C1 (en) 2016-04-21
KR20120050479A (en) 2012-05-18
JP2017008064A (en) 2017-01-12
IL218043A0 (en) 2012-04-30
EP2464357A2 (en) 2012-06-20
WO2011019617A3 (en) 2011-06-30
AU2015238850B2 (en) 2017-08-24
EP3603646B1 (en) 2024-04-03
CA2770683A1 (en) 2011-02-17
AU2010282731B2 (en) 2015-08-13
MX366076B (en) 2019-06-27
EP2464357A4 (en) 2013-08-14
TW201733593A (en) 2017-10-01
KR101791828B1 (en) 2017-10-31
EA201270226A1 (en) 2012-09-28
US20110059917A1 (en) 2011-03-10
ES2742750T3 (en) 2020-02-17
MX2012001885A (en) 2012-06-01
MX338746B (en) 2016-04-29
AU2017210660A1 (en) 2017-08-31
CN102655869A (en) 2012-09-05
CN106265695A (en) 2017-01-04
CN102655869B (en) 2016-08-10
KR20170121323A (en) 2017-11-01
CN105663146A (en) 2016-06-15
JP5978130B2 (en) 2016-08-24
EP2464357B1 (en) 2019-05-22
AU2015238850A1 (en) 2015-10-29
ZA201702812B (en) 2018-08-29
ZA201707693B (en) 2019-05-29
US11305016B2 (en) 2022-04-19
WO2011019617A2 (en) 2011-02-17
AU2017210660C1 (en) 2019-10-24
CN105663146B (en) 2020-09-11
KR101880032B1 (en) 2018-07-20
US9901637B2 (en) 2018-02-27
EP3603646A1 (en) 2020-02-05
BR112012003372A2 (en) 2019-09-24
IL218043B (en) 2019-07-31
JP2013501790A (en) 2013-01-17

Similar Documents

Publication Publication Date Title
IN2012DN02137A (en)
PH12012502399A1 (en) Combination therapy methods for treating proliferative diseases
PH12014501560A1 (en) Carbamate compounds and of making and using same
SG10201810888XA (en) Compositions and methods comprising bupropion or related compounds and dextromethorphan
EP3501546A3 (en) Cysteine drug conjugates and use of same
MX2011007589A (en) Treatment of a cancer using a combination of bendamustine and an anti-cd20 antibody.
CO6761350A2 (en) Derivatives of 2,3-dihydroimidazo [1,2-c] quinazoline substituted with amino alcohols that are useful for treating hyperproliferative disorders and diseases associated with angiogenesis
AR096892A1 (en) A PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF MELANOMA
IN2014DN08598A (en)
MY175764A (en) Extended-release formulation for reducing the frequency of urination and method of use thereof
BR112014009365A2 (en) method for inhibiting deubiquitination activity
PH12013501163A1 (en) Compositions comprising a p13k inhibitor and a mek inhibitor and their use for treating cancer
WO2014071168A3 (en) Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients
WO2009019708A3 (en) Pharmaceutical compositions and methods for the treatment of cancer
BR112013001462B8 (en) COMPOSITIONS
BR112012006070A2 (en) compositions and methods for treating seizure disorders.
MY171526A (en) Pharmaceutical formulation for reducing frequency of urination and method of use thereof
BR112013004714A2 (en) "combinations of hdac inhibitors with thrombocytopenia drugs and their uses"
BR112015005392A2 (en) tablet formulation of a phosphatidylinositol 3 kinase inhibitor
TN2014000418A1 (en) Methods for treating cancer using pi3k inhibitor and mek inhibitor
WO2012001064A3 (en) Use of alpha-adrenergic receptor agonist for preventing or treating skin tumor
UA111785C2 (en) A COMPOSITION FOR THE TREATMENT OF Warts And A WAY OF TREATMENT
MX2011006758A (en) Pharmaceutical composition for use against inflammation and pain.
CR20120618A (en) ASSOCIATION OF INHIBITORS OF XANTINA OXIDASE AND THE INSTATINE AND ITS USE
WO2014170820A3 (en) A pharmaceutical combination for treating tuberculosis